MedPath

K-232 phase 3 long-term administration study

Phase 3
Completed
Conditions
primary open-angle glaucoma (broad definition), exfoliative glaucoma, pigmentary glaucoma, ocular hypertension
Registration Number
JPRN-jRCT2080225063
Lead Sponsor
Kowa Company, Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
160
Inclusion Criteria

1.POAG (broad definition), exfoliative glaucoma, pigmentary glaucoma or OH patients
2.Baseline IOP => 15mmHg

Exclusion Criteria

1.Patients whose visual acuity is below 0.3
2.Patients with severe visual field defects
3.Patients thought to wear contact lenses
etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath